Segment Information |
SEGMENT INFORMATION The Company operates and reports its results in three separate business segments consisting of the Life Sciences, Diagnostics and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals. Detailed segment data for the years ended December 31 is as follows ($ in millions): | | | | | | | | | | | | | | | | | | | 2020 | | 2019 | | 2018 | Sales: | | | | | | Life Sciences | $ | 10,576 | | | $ | 6,951 | | | $ | 6,471 | | Diagnostics | 7,403 | | | 6,561 | | | 6,258 | | Environmental & Applied Solutions | 4,305 | | | 4,399 | | | 4,320 | | Total | $ | 22,284 | | | $ | 17,911 | | | $ | 17,049 | | | | | | | | Operating profit: | | | | | | Life Sciences | $ | 2,054 | | | $ | 1,401 | | | $ | 1,229 | | Diagnostics | 1,538 | | | 1,134 | | | 1,074 | | Environmental & Applied Solutions | 979 | | | 1,052 | | | 988 | | Other | (340) | | | (318) | | | (236) | | Total | $ | 4,231 | | | $ | 3,269 | | | $ | 3,055 | | | | | | | | Identifiable assets: | | | | | | Life Sciences | $ | 48,919 | | | $ | 22,381 | | | $ | 22,122 | | Diagnostics | 15,042 | | | 14,442 | | | 14,031 | | Environmental & Applied Solutions | 5,083 | | | 4,882 | | | 4,637 | | Other | 7,117 | | | 20,377 | | | 1,201 | | Discontinued operations | — | | | — | | | 5,842 | | Total | $ | 76,161 | | | $ | 62,082 | | | $ | 47,833 | | | | | | | | Depreciation and amortization: | | | | | | Life Sciences | $ | 1,053 | | | $ | 487 | | | $ | 471 | | Diagnostics | 602 | | | 582 | | | 589 | | Environmental & Applied Solutions | 110 | | | 111 | | | 109 | | Other | 10 | | | 9 | | | 9 | | Total | $ | 1,775 | | | $ | 1,189 | | | $ | 1,178 | | | | | | | | Capital expenditures, gross: | | | | | | Life Sciences | $ | 306 | | | $ | 143 | | | $ | 140 | | Diagnostics | 447 | | | 435 | | | 380 | | Environmental & Applied Solutions | 36 | | | 54 | | | 57 | | Other | 2 | | | 4 | | | 7 | | Total | $ | 791 | | | $ | 636 | | | $ | 584 | |
Operations in Geographical Areas: | | | | | | | | | | | | | | | | | | | Year Ended December 31 | ($ in millions) | 2020 | | 2019 | | 2018 | Sales: | | | | | | United States | $ | 8,616 | | | $ | 6,660 | | | $ | 6,134 | | China | 2,688 | | | 2,308 | | | 2,170 | | Germany | 1,238 | | | 1,013 | | | 1,082 | | All other (each country individually less than 5% of total sales) | 9,742 | | | 7,930 | | | 7,663 | | Total | $ | 22,284 | | | $ | 17,911 | | | $ | 17,049 | | | | | | | | Property, plant and equipment, net: | | | | | | United States | $ | 1,317 | | | $ | 1,077 | | | $ | 1,081 | | Sweden | 553 | | | 32 | | | 32 | | United Kingdom | 214 | | | 163 | | | 157 | | Germany | 207 | | | 163 | | | 169 | | All other (each country individually less than 5% of total property, plant and equipment, net) | 971 | | | 867 | | | 811 | | Total | $ | 3,262 | | | $ | 2,302 | | | $ | 2,250 | |
Sales by Major Product Group: | | | | | | | | | | | | | | | | | | | Year Ended December 31 | ($ in millions) | 2020 | | 2019 | | 2018 | Analytical and physical instrumentation | $ | 2,443 | | | $ | 2,464 | | | $ | 2,437 | | Research and medical products | 17,979 | | | 13,512 | | | 12,686 | | Product identification | 1,862 | | | 1,935 | | | 1,926 | | Total | $ | 22,284 | | | $ | 17,911 | | | $ | 17,049 | |
|